Fortress Biotech, Inc.·4

Jan 4, 9:25 PM ET

Lorenz Kevin 4

4 · Fortress Biotech, Inc. · Filed Jan 4, 2023

Insider Transaction Report

Form 4
Period: 2023-01-01
Lorenz Kevin
Director
Transactions
  • Award

    COMMON STOCK, PAR VALUE $0.001

    2023-01-01+50,000314,572 total
Holdings
  • COMMON STOCK, PAR VALUE $0.001

    (indirect: By Spouse)
    10,000
Footnotes (1)
  • [F1]One-third of the shares will vest on each of January1, 2024, 2025 and 2026, subject to continued service.

Documents

2 files